Dimethylformamide → 1,2-Dihydrobenzo[b]pyrrolo[3,2,1-jk][1,2,4]triazolo[4,3-d][1,4]benzodiazepine
Reaction equation
[CH2:1]1[N:12]2[C:13]3[C:3](=[CH:4][CH:5]=[CH:6][C:7]=3[C:8](=S)[NH:9][C:10]3[CH:17]=[CH:16][CH:15]=[CH:14][C:11]=32)[CH2:2]1.O.[NH2:20]N.C[N:23]([CH3:26])C=O>>[CH2:6]1[C:7]2[C:8]3[N:9]([CH:26]=[N:23][N:20]=3)[C:10]3[CH:17]=[CH:16][CH:15]=[CH:14][C:11]=3[N:12]3[CH:1]=[CH:2][C:3]([C:13]=23)=[CH:4][CH2:5]1Participants
4
Procedure
1,2-Dihydrobenzo[b]pyrrolo[3,2,1-jk][1,4]benzodiazepin-6-thione (5 g), hydrazine monohydrate (5 ml) and dimethylformamide (150 ml) were combined and refluxed overnight. The reaction mixture was concentrated under reduced pressure and the residue was purified by high performance liquid chromatography (2% methanol/dichloromethane) to yield 3.5 g (68.2%) of product. Recrystallization from tetrahydrofuran gave the analytical sample, mp 177°-178° C.
Workup
- temperaturerefluxed overnight
- concentrationThe reaction mixture was concentrated under reduced pressure
- customthe residue was purified by high performance liquid chromatography (2% methanol/dichloromethane)
Sources & evidence
- ORD record
- ord-ff2b865f3e2f463a9ea1d03a9b2ec8d0
- Source dataset
- uspto-grants-1991_01
- Patent number
- US04983601
Reaction notes
Loading…